A case report on sorafenib induced adverse reaction
Artículo
| IMSEAR
| ID: sea-213941
ABSTRACT
Sorafenib is an oral multi-kinase inhibitor used primarily in the treatment of hepatic cellular carcinoma, renal cell carcinoma, and thyroid carcinoma. Hand-foot syndrome also is known as palmar-plantar erythrodysesthesia causes reddening, numbness, swelling of palms of hands and soles of feet. In this report, a known case of renal cell carcinoma, post right nephrectomy patient on treatment with tab sorafenib had developed the hand-foot syndrome
Texto completo:
Disponible
Índice:
IMSEAR (Asia Sudoriental)
Año:
2019
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS